SEC Filings
10-K, 10-Q, 8-K, 20-F, and 6-K source pages with page-level citations, metadata, markdown, and gold labels.
A Wall Street-style view of the companies already covered in the Agentii database: sector allocation, ticker breadth, filing depth, and sub-industry clusters for agent-ready financial research.
Designed for analyst scanning across sectors, industries, sub-industries, and representative ticker clusters without losing the broad market coverage context.
Live financial sources are served today with consistent metadata, page content, labels, and citations. Q3 sources are shown separately so teams can plan upcoming healthcare and regulatory workflows.
10-K, 10-Q, 8-K, 20-F, and 6-K source pages with page-level citations, metadata, markdown, and gold labels.
Full filing index with form type, fiscal period, filing date, source institution, and citation IDs.
Report dates, fiscal quarters, estimated EPS and revenue, and actuals for agent planning.
Ticker, CIK, exchange, sector, industry, sub-industry, IR links, and SEC company URLs.
Structured financial facts connected to fiscal periods, concepts, units, and filing provenance.
ClinicalTrials.gov phase, status, sponsor, intervention, and signal labels for biotech agents.
NDA, BLA, and ANDA approval records with regulatory signal and therapeutic-area context.
Adverse-event reports with drug-reaction pairs, seriousness, outcomes, and demographics.
Ask for an analysis, not an endpoint. Agentii skills plan the research, search filings, read the right pages, and return analyst-ready conclusions with source-level citations.
Agentii is for people who need financial data that an AI agent can query, cite, and reason over immediately: filings, company profiles, earnings context, and upcoming healthcare data sources in the same response contract.
Ask an agent to compare management guidance, risk factors, and segment commentary across filings without losing page-level citations.
Track earnings, company updates, and source freshness across hundreds of covered tickers by sector and sub-industry.
Prepare agents for FDA, clinical-trial, and adverse-event context when regulatory signals become part of the same retrieval layer.
The difference is not just having filings in a database. It is getting source-aware summaries, metadata, and page content in a shape an agent can actually use without a custom retrieval system.
Pay monthly. Cancel anytime. All plans include API documentation and agent-ready response format.
Launch discount — prices locked for first 100 subscribers
10K credits/mo
~20 deep analyses/mo
For analyzing a handful of stocks per quarter. Full access to all 506 US stocks.
50K credits/mo
~100 analyses/mo
For running daily screens across sectors. Full access to all 506 US stocks.
500K credits/mo
200–500 analyses/mo
For funds and data teams. Full access to all 506 US stocks.
All plans include access to all 506 US stocks. Credits determine how many analyses you can run per month, not which tickers you can query. Paid users: $10 for 5,000 extra credits + 500 daily sign-in credits. Free trial: 2,000 credits for 7 days, no credit card.
Search SEC filings, earnings events, FDA records, clinical trials, and company profiles through one citation-backed data layer. Start testing real workflows in minutes.